SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 70.62 |
| Enterprise Value ($M) | 21.91 |
| Book Value ($M) | 52.28 |
| Book Value / Share | 0.63 |
| Price / Book | 1.35 |
| NCAV ($M) | 31.75 |
| NCAV / Share | 0.38 |
| Price / NCAV | 2.22 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.63 |
| Return on Assets (ROA) | -0.89 |
| Return on Equity (ROE) | -1.49 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.25 |
| Current Ratio | 6.25 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 51.41 |
| Assets | 71.94 |
| Liabilities | 19.66 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | New Enterprise Associates 16, L.P. | 17.40 | 65.31 | |
| 13D/A | Leen Ann M. | 2.89 | -11.05 | |
| 13D/A | Eastern Capital LTD | 5.00 | -11.19 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| Annual Report – 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 448,145 | 1,282,576 | 34.94 | |
| 51,952 | 258,012 | 20.14 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| MOR – MorphoSys AG | MORF – Morphic Holding Inc |
| MREO – Mereo BioPharma Group plc | MRNA – Moderna Inc |
| MRNS – Marinus Pharmaceuticals Inc |
Financial data and stock pages provided by
Fintel.io
